ACE2 mediates the entry of SARS-CoV-2 into host cells as a receptor, so blocking the combination between ACE2 and SARS-CoV-2 or inhibiting ACE2 activity may reduce viral infection. This evidence concerns the gene ACE2 and viral infectious disease.